In conclusion, baseline albumin levels allow appropriate prediction of patients with NAFLD at higher risk of developing death or OLT, liver-related death, HCC, decompensated cirrhosis, and gastroesophageal varices. This evidence concerns the gene ALB and hepatocellular carcinoma.